Clinical Trials Logo

Clinical Trial Summary

This purpose of this study is to validate two measures of chronic itching in kids: itch severity (ItchyQuant) and the impact on their quality of life (ItchyQoL).


Clinical Trial Description

There are many diseases that affect children where the primary symptom is pruritus. This study aims to validate an age appropriate pediatric version of the ItchyQoL, a pruritus-specific quality of life instrument, and the ItchyQuant, a self-reported itch severity scale, to better understand how pruritus affects the pediatric population. These instruments will comprehensively capture the severity and impact of pruritus in children. The physicians want to explore the opportunity to integrate patient-reported outcome measures (PROM) as a patient-reported tool in the ambulatory setting. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02672579
Study type Observational
Source Emory University
Contact
Status Completed
Phase
Start date May 2015
Completion date June 28, 2018

See also
  Status Clinical Trial Phase
Completed NCT05038982 - Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin Phase 2
Completed NCT01951274 - VPD-737 for Treatment of Chronic Pruritus Phase 2
Completed NCT04949893 - Causes of Chronic Pruritus
Completed NCT02651714 - Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis Phase 2
Completed NCT03751111 - Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone Phase 1/Phase 2
Completed NCT04693195 - A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis Phase 2
Not yet recruiting NCT05678309 - Establishment of a Patient Library in Patients With Pruritus Sine Materia